U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H32O2
Molecular Weight 292.4562
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3.BETA.-ANDROSTANEDIOL

SMILES

C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O

InChI

InChIKey=CBMYJHIOYJEBSB-YSZCXEEOSA-N
InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,17-,18-,19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H32O2
Molecular Weight 292.4562
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
ERbeta: recent understanding of estrogen signaling.
2010-09
Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.
2010-09
The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta.
2010-09
Effects of CYP7B1-mediated catalysis on estrogen receptor activation.
2010-09
Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry.
2010-08
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.
2010-04-13
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
2009-12-10
Assessment of metabolic capabilities of PLHC-1 and RTL-W1 fish liver cell lines.
2009-12
MMP7 expression regulated by endocrine therapy in ERbeta-positive colon cancer cells.
2009-09-29
Androgens upregulate cyp19a1b (aromatase B) gene expression in the brain of zebrafish (Danio rerio) through estrogen receptors.
2009-05
The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
2009-05
Detection of anabolic steroids in dietary supplements: the added value of an androgen yeast bioassay in parallel with a liquid chromatography-tandem mass spectrometry screening method.
2009-04-01
Reductive 17beta-hydroxysteroid dehydrogenases in the sulfatase pathway: critical in the cell proliferation of breast cancer.
2009-03-25
A role for the androgen metabolite, 5alpha-androstane-3beta,17beta-diol, in modulating oestrogen receptor beta-mediated regulation of hormonal stress reactivity.
2009-03
Epimerase activity of the human 11beta-hydroxysteroid dehydrogenase type 1 on 7-hydroxylated C19-steroids.
2009-03
Steroid hormone transforming aldo-keto reductases and cancer.
2009-02
Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice.
2008-11
An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol.
2008-05
CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling.
2008-04
Estrogen sensitivity of target genes and expression of nuclear receptor co-regulators in rat prostate after pre- and postnatal exposure to the ultraviolet filter 4-methylbenzylidene camphor.
2007-12
5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
2007-12
5Alpha-androstane-3beta,7alpha,17beta-triol and 5alpha-androstane-3beta,7beta,17beta-triol as substrates for the human 11beta-hydroxysteroid dehydrogenase type 1.
2007-11
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.
2007-09-15
Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells.
2007-07
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006-11
Effects of 3-beta-diol, an androgen metabolite with intrinsic estrogen-like effects, in modulating the aquaporin-9 expression in the rat efferent ductules.
2006-10-06
Triphenyltin alters androgen metabolism in the sea urchin Paracentrotus lividus.
2006-09-12
Regulation of steroid hydroxylase CYP7B1 by androgens and estrogens in prostate cancer LNCaP cells.
2006-06-02
17beta-estradiol induces apoptosis in the developing rodent prostate independently of ERalpha or ERbeta.
2006-01
Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity.
2006-01
The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
2005-06-15
Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney.
2004-12-01
The human cytochrome P4507B1: catalytic activity studies.
2004-12
Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
2004-12
HPLC-RIA analysis of steroid hormone profile in a virilizing stromal tumor of the ovary.
2004-10-29
Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements.
2004-07
Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action.
2004-03-12
Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.
2004
Proposed mechanism for sperm chromatin condensation/decondensation in the male rat.
2003-02-11
Photoaffinity labeling of human sex hormone-binding globulin using 17alpha-alkylamine derivatives of 3beta-androstanediol substituted with azidonitrophenylamido, azidonitrophenylamino, or trifluoroazidonitrophenylamino chromophores. Localization of Trp-84 in the vicinity of the steroid-binding site.
2001-12-18
Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation.
2001-06-29
In-vitro metabolism of [3H]testosterone by scalp and back skin: conversion of testosterone into 5alpha-androstane-3beta, 17beta-diol.
1977-03
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:48:25 GMT 2025
Edited
by admin
on Mon Mar 31 17:48:25 GMT 2025
Record UNII
6J0K4253QD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3.BETA.-ANDROSTANEDIOL
Common Name English
MAXTERONE
Preferred Name English
NSC-50891
Code English
5.ALPHA.-ANDROSTANE-3.BETA.,17.BETA.-DIOL
Systematic Name English
3BETA,17BETA-DIHYDROXY-5ALPHA-ANDROSTANE
Systematic Name English
3.BETA.,17.BETA.-ANDROSTANEDIOL
Common Name English
3.BETA.-ADIOL
Common Name English
ANDROSTANE-3,17-DIOL, (3.BETA.,5.ALPHA.,17.BETA.)-
Systematic Name English
3.BETA.,17.BETA.-DIHYDROXY-5.ALPHA.-ANDROSTANE
Systematic Name English
Classification Tree Code System Code
LOINC 9640-4
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
DEA NO. 4000
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
LOINC 15026-8
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
LOINC 1850-7
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
LOINC 23815-4
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
Code System Code Type Description
NSC
50891
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
EPA CompTox
DTXSID8022379
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
DRUG BANK
DB03882
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
FDA UNII
6J0K4253QD
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
ECHA (EC/EINECS)
209-334-3
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
WIKIPEDIA
3?-Androstanediol
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
CHEBI
18329
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
CAS
571-20-0
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
PUBCHEM
242332
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
CHEBI
27727
Created by admin on Mon Mar 31 17:48:25 GMT 2025 , Edited by admin on Mon Mar 31 17:48:25 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
PARENT -> METABOLITE
IN VITRO
Related Record Type Details
ACTIVE MOIETY